Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2D 4 pseudogene

Molecular classification: Pseudogene, Non-coding RNA

Overview

Ubiquitin-conjugating enzyme E2D 4 pseudogene (ENSG00000250315) is a non-functional genomic sequence that resembles the coding gene for the ubiquitin-conjugating enzyme E2D 4 (UBE2D4) but does not encode a functional protein. Like other processed pseudogenes, it may arise from reverse transcription and reintegration of mRNA into the genome, typically lacking introns and sometimes containing polyadenylation tracts. Pseudogenes sometimes play regulatory roles in the transcriptome, but there is no specific evidence for functional activity or disease linkage for this pseudogene. In summary, ENSG00000250315 is a bona fide human pseudogene, not considered a therapeutic or molecular target, with no direct role in drug interactions or disease pathogenesis.

Other names: UBE2D4 pseudogene (putative)

Biological functions

While pseudogenes like this one do not encode functional proteins, some pseudogene transcripts can play a regulatory role in gene expression, such as acting as RNA decoys or influencing microRNA availability, but there is no specific evidence that this particular pseudogene (ENSG00000250315) has a clear biological function

Disease associations

There is no direct evidence implicating this specific pseudogene in disease; however, in general, dysregulation of pseudogene expression has been observed in cancer and other contexts. No direct disease association is known for ENSG00000250315.

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2D 4 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2D 4 pseudogene.

Explore the full profile